dr. glen lack bert, the chairman of essex irb, is a retired pediatrician. signature gave us the go-ahead to begin human testing. you recently approved a trial for a company called mallum kinetics. >> okay. >> i need to let you know that mallum kinetics is really "dateline" nbc. >> oh. >> i told dr. lambert that the test plan his board approved was for a drug identical to vioxx. how could you aof propprove a pl that's already been known to be pulled off the market and have been been linked to deaths, strokes and heart attacks? >> i don't know. i really do not know how that could have occurred. we're very thorough in our reviews of protocols. >> but if excess really did thoroughly review the safety of our plan, like review boards are supposed to, an easy internet search would have shown our drug wasn't safe because we used the same abbreviation, mk-0966, as merck did for vioxx. the reality doctor, is this, had you just used google you would have figured this out. review boards are also supposed to make sure the doctor running a study is qualified. remember, t